Effectiveness of diclofenac versus paracetamol in knee osteoarthritis: A randomised controlled trial in primary care

British Journal of General Practice

Volumn 65, Issue 637, 2015, Pages e530-e537

  Verkleij, Saskia P J ^a   Luijsterburg, Pim A J ^a   Willemsen, Sten P ^a   Koes, Bart W ^a   Bohnen, Arthur M ^a   Bierma Zeinstra, Sita M A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Diclofenac; General practice; Knee osteoarthritis; Paracetamol; Randomised controlled trial

Indexed keywords

DICLOFENAC; PARACETAMOL; ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GENERAL PRACTICE; HUMAN; IMMUNOPATHOLOGY; KNEE FUNCTION; KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; OPEN STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SKIN DISEASE; SKIN MANIFESTATION; TREATMENT DURATION; VESTIBULAR DISORDER; CLINICAL PROTOCOL; COMPARATIVE STUDY; DRUG ADMINISTRATION; EPIDEMIOLOGY; MIDDLE AGED; NETHERLANDS; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PRIMARY HEALTH CARE; TREATMENT OUTCOME; WEIGHT BEARING;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL PROTOCOLS; DICLOFENAC; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; PATIENT SATISFACTION; PRIMARY HEALTH CARE; TREATMENT OUTCOME; WEIGHT-BEARING;

EID: 84938839713     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp15X686101     Document Type: Article

References (27)

1. Buckwalter JA, Martin JA. Osteoarthritis. Adv Drug Deliv Rev 2006; 58(2): 150-167.
2. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003; 81(9): 646-656.
3. Belo JN, Bierma-Zeinstra SMA, Raaijmakers AJ, van der Wissel F. Dutch general practice guideline 'Non-traumatic knee disorders in adults'. [In Dutch]. Huisarts en Wetenschap 2008; 51(5): 229-240.
4. Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003; 62(12): 1145-1155.
5. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007; 15(9): 981-1000.
6. Smink AJ, van den Ende CH, Vliet Vlieland TP, et al. "Beating osteoARThritis": development of a stepped care strategy to optimize utilization and timing of non-surgical treatment modalities for patients with hip or knee osteoarthritis. Clin Rheumatol 2011; 30(12): 1623-1629.
7. Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1, 799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 2000; 43(2): 378-385.
8. Ausiello JC, Stafford RS. Trends in medication use for osteoarthritis treatment. J Rheumatol 2002; 29(5): 999-1005.
9. Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010; 18(4): 476-499.
10. Barozzi N, Tett SE. Perceived barriers to paracetamol (acetaminophen) prescribing, especially following rofecoxib withdrawal from the market. Clin Rheumatol 2009; 28(5): 509-519.
11. Boureau F, Schneid H, Zeghari N, et al. The IPSO study: ibuprofen, paracetamol study in osteoarthritis. A randomised comparative clinical study comparing the efficacy and safety of ibuprofen and paracetamol analgesic treatment of osteoarthritis of the knee or hip. Ann Rheum Dis 2004; 63(9): 1028-1034.
12. Case JP, Baliunas AJ, Block JA. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. Arch Intern Med 2003; 163(2): 169-178.
13. Yelland MJ, Nikles CJ, McNairn N, et al. Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials. Rheumatology (Oxford) 2007; 46(1): 135-140.
14. Batlle-Gualda E, Román Ivorra J, Martín-Mola E, et al. Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double-blind 6-week randomized controlled trial. Osteoarthritis Cartilage 2007; 15(8): 900-908.
15. Lequesne M, Fannius J, Reginster JY, et al. Floctafenin versus acetaminophen for pain control in patients with osteoarthritis in the lower limbs. Franco-Belgian Task Force. Rev Rhum Engl Ed 1997; 64(5): 327-333.
16. Verkleij SP, Luijsterburg PA, Koes BW, et al. Effectiveness of diclofenac versus acetaminophen in primary care patients with knee osteoarthritis: [NTR1485], DIPA-trial: design of a randomized clinical trial. BMC Musculoske let Disord 2010; 11: 7.
17. Heintjes EM, Berger MY, Koes BW, Bierma-Zeinstra SM. Knee disorders in primary care: design and patient selection of the HONEUR knee cohort. BMC Musculoske let Disord 2005; 6: 45.
18. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29(8): 1039-1049.
19. Roos EM, Lohmander LS. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes 2003; 1: 64.
20. Brooks R. EuroQol: the current state of play. Health Policy 1996; 37(1): 53-72.
21. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16(4): 494-502.
22. Harrell Jr FE. Regression modeling strategies. New York, NY: Springer-Verlag New York Inc., 2010.
23. Cohen J. Statistical power analysis for the behavioral sciences. 2nd edn. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
24. Boutron I, Moher D, Altman DG, et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008; 148(4): 295-309.
25. Schnitzer TJ, Tesser JR, Cooper KM, Altman RD. A 4-week randomized study of acetaminophen extended-release vs rofecoxib in knee osteoarthritis. Osteoarthritis Cartilage 2009; 17(1): 1-7.
26. Trijau S, Avouac J, Escalas C, et al. Influence of flare design on symptomatic efficacy of non-steroidal anti-inflammatory drugs in osteoarthritis: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage 2010; 18(8): 1012-1018.
27. Perrot S, Rozenberg S, Moyse D, et al. Comparison of daily, weekly or monthly pain assessments in hip and knee osteoarthritis. A 29-day prospective study. Joint Bone Spine 2011; 78(5): 510-515.